Diabetes and stroke: Part two - Treating diabetes and stress hyperglycemia in hospitalized stroke patients

被引：5

作者：

Burroughs V. ^{[1
]}

Weinberger J. ^{[1
]}

机构：

[1] Department of Medicine, North General Hospital, New York, NY 10035-2709

来源：

Current Cardiology Reports | 2006年 / 8卷 / 1期

关键词：

Stroke Patient; Insulin Dose; Subcutaneous Insulin; Correction Dose; Stress Hyperglycemia;

D O I：

10.1007/s11886-006-0007-0

中图分类号：

学科分类号：

摘要：

It is well established that strict glycemic control for the hospitalized stroke patient is associated with improved outcome compared with poor control. This is particularly true for the stroke patients because hyperglycemia can adversely affect ischemic damage. A blood sugar level of less than 110 mg/dL is recommended for critically ill patients and should be achieved by intravenous insulin administration in an intensive care unit setting. Many stroke patients are unable to swallow, and insulin requirement must be readjusted carefully to conform to the nutritional state of the patient. The transition from intravenous insulin to subcutaneous insulin or oral antihyperglycemic agents must be carefully monitored. Careful discharge planning of diabetic care for the stroke patient is necessary to prevent long-term sequelae of inadequate control. Copyright © 2006 by Current Science Inc.

引用

页码：29 / 32

页数：3

共 26 条

[11]

Montori V.M., Bistrian B.R., McMahon M.M., Hyperglycemia in acutely ill patients, JAMA, 288, pp. 2167-2169, (2002)

[12]

Hirsch I.B., Braithwaite S.S., Verderese C.A., Practical, Management of Inpatient Hyperglycemia, pp. 1-41, (2005)

[13]

Trence D.L., Kelly J.L., Hirsch I.B., The rationale and management of hyperglycemia for in-patients with cardiovascular disease: Time for a change, J Clin Endocrinol Metab, 88, pp. 2430-2437, (2003)

[14]

Braithwaite S.S., Buie M.M., Thompson C.L., Et al., Hospital hypoglycemia: Not only treatment but also prevention, Endocr Pract, 10, SUPPL.l2, pp. 89-99, (2004)

[15]

Standards of medical care in diabetes, Diabetes Care, 28, (2005)

[16]

Schloerb P.R., Glucose in parenteral nutrition: A survey of US medical centers, J Parenter Enteral Nutr, 28, pp. 447-452, (2004)

[17]

Jeejeebhoy K.N., Permissive underfeeding of the critically ill patient, Nutr Clin Pract, 19, pp. 477-480, (2004)

[18]

Campbell K.B., Braithwaite S.S., Hospital management of hyperglycemia, Clin Diabetes, 22, pp. 81-88, (2004)

[19]

Bode B.W., Braithwaite S.S., Steed R.D., Davidson P.C., Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy, Endocr Pract, 10, pp. 71-80, (2004)

[20]

Braithwaite S.S., Case Study. Five steps to freedom: Dose titration for type 2 diabetes using basal-prandial-correction insulin therapy, Clin Diabetes, 23, pp. 39-43, (2005)

← 1 2 3 →